Trade Report: Today, BeiGene Ltd. (BGNE) Director Thomas Malley Buys 30,000 Shares

Today, BeiGene Ltd. (BGNE) Director Thomas Malley Buys 30,000 Shares

BeiGene Ltd. (NASDAQ:BGNE) Director Thomas Malley purchased 30,000 shares of the business’s stock in a transaction dated Wednesday, November 23rd. The shares were purchased at an average cost of $32.00 per share, for a total transaction of $960,000.00. Following the completion of the purchase, the director now directly owns 30,000 shares of the company’s stock, valued at approximately $960,000. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

BeiGene Ltd. (NASDAQ:BGNE) opened at 30.88 on Tuesday. BeiGene Ltd. has a 12 month low of $22.51 and a 12 month high of $37.89. The stock’s 50 day moving average price is $32.84 and its 200-day moving average price is $30.18. The company’s market capitalization is $1.02 billion.

BeiGene (NASDAQ:BGNE) last released its quarterly earnings data on Thursday, November 10th. The company reported ($1.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.78) by $0.30. On average, equities research analysts predict that BeiGene Ltd. will post ($3.96) EPS for the current fiscal year.

A number of analysts have recently commented on the company. Maxim Group set a $41.00 price target on BeiGene and gave the company a “buy” rating in a research note on Saturday, October 8th. Zacks Investment Research raised BeiGene from a “sell” rating to a “hold” rating in a research note on Monday, November 21st. Finally, Cowen and Company reissued a “buy” rating on shares of BeiGene in a research note on Friday, October 7th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $40.00.

Several hedge funds have recently added to or reduced their stakes in BGNE. BlackRock Inc. raised its position in shares of BeiGene by 3,410.1% in the second quarter. BlackRock Inc. now owns 3,826 shares of the company’s stock worth $114,000 after buying an additional 3,717 shares in the last quarter. Bank of Montreal Can acquired a new position in shares of BeiGene during the second quarter worth $191,000. BlackRock Institutional Trust Company N.A. raised its position in shares of BeiGene by 67.9% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 6,404 shares of the company’s stock worth $191,000 after buying an additional 2,589 shares in the last quarter. Credit Suisse AG raised its position in shares of BeiGene by 9.1% in the third quarter. Credit Suisse AG now owns 12,000 shares of the company’s stock worth $370,000 after buying an additional 1,000 shares in the last quarter. Finally, Susquehanna International Group LLP acquired a new position in shares of BeiGene during the third quarter worth $455,000. Institutional investors own 32.25% of the company’s stock.

About BeiGene

Related posts

Leave a Comment